• 1. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 4’-Methyl-2(p-tolylsulfonyl)acetophenone (CAS No. 61820-95-9)

4’-Methyl-2(p-tolylsulfonyl)acetophenone, identified by the Chemical Abstracts Service Number (CAS No.) 61820-95-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and synthetic organic chemistry. This compound, featuring a unique structural motif with a methyl-substituted benzophenone core and a p-tolylsulfonyl group, exhibits promising properties that make it a valuable intermediate in the synthesis of various biologically active molecules.

The molecular structure of 4’-Methyl-2(p-tolylsulfonyl)acetophenone consists of a benzene ring substituted at the 4-position with a methyl group and at the 2-position with a p-tolylsulfonyl moiety. This arrangement imparts distinct electronic and steric properties to the molecule, which are highly relevant in medicinal chemistry. The presence of the sulfonyl group enhances the compound's reactivity, making it a versatile building block for further functionalization. Such structural features are particularly useful in designing molecules with enhanced binding affinity and selectivity towards target biological receptors.

In recent years, 4’-Methyl-2(p-tolylsulfonyl)acetophenone has been explored as a key intermediate in the synthesis of novel pharmaceutical agents. Its role in constructing complex scaffolds has been demonstrated in several high-profile studies. For instance, researchers have leveraged its reactivity to develop derivatives with potential applications in anti-inflammatory and anticancer therapies. The compound's ability to undergo selective transformations, such as nucleophilic aromatic substitution and cross-coupling reactions, allows for the efficient construction of intricate molecular architectures.

One of the most compelling aspects of 4’-Methyl-2(p-tolylsulfonyl)acetophenone is its utility in generating heterocyclic compounds, which are prevalent in many bioactive natural products and synthetic drugs. By serving as a precursor for cyclization reactions, this compound enables the rapid assembly of fused ring systems, such as pyrazoles, pyrimidines, and thiophenes. These heterocycles are known for their broad spectrum of biological activities, including antimicrobial, antiviral, and anti-inflammatory effects. The incorporation of 4’-Methyl-2(p-tolylsulfonyl)acetophenone into synthetic protocols has thus facilitated the discovery of new pharmacophores with therapeutic potential.

Advances in computational chemistry have further highlighted the significance of 4’-Methyl-2(p-tolylsulfonyl)acetophenone as a molecular scaffold. Molecular modeling studies have revealed that derivatives derived from this compound can exhibit optimized interactions with biological targets due to their well-defined three-dimensional structures. These studies have guided the rational design of novel analogs with improved pharmacokinetic profiles and reduced side effects. The integration of experimental data with computational predictions has been instrumental in fine-tuning synthetic strategies to maximize yield and purity.

The pharmaceutical industry has also shown interest in 4’-Methyl-2(p-tolylsulfonyl)acetophenone due to its potential as an intermediate in drug development pipelines. Its structural versatility allows for rapid diversification of chemical libraries, enabling high-throughput screening programs to identify lead compounds efficiently. Moreover, its stability under various reaction conditions makes it a reliable choice for large-scale syntheses required for clinical trials and commercial production.

Recent research has expanded the applications of 4’-Methyl-2(p-tolylsulfonyl)acetophenone beyond traditional pharmaceutical uses. In materials science, for example, derivatives of this compound have been investigated for their optical properties, making them candidates for use in organic electronics and photovoltaic devices. The ability to fine-tune electronic characteristics through structural modifications offers exciting possibilities for developing next-generation materials with enhanced performance.

In conclusion, 4’-Methyl-2(p-tolylsulfonyl)acetophenone (CAS No. 61820-95-9) represents a cornerstone compound in modern chemical synthesis and drug discovery. Its unique structural features and reactivity profile have positioned it as an indispensable tool for medicinal chemists seeking to develop innovative therapeutic agents. As research continues to uncover new applications for this compound, its importance is likely to grow further, solidifying its role as a key player in both academic and industrial chemistry.

• 31378-03-7(2-(4-methylbenzenesulfonyl)-1-phenylethan-1-one)
• 3406-03-9(2-(Phenylsulfonyl)acetophenone)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)